LI
LIFS.US Life Stem Genetics
- Market cap
- USD 24.6K
- P/E
- -
- P/B
- 0.13x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jul 2026.
Is LIFS.US undervalued?
Graham numberThe Graham number of Life Stem Genetics cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Life Stem Genetics fundamental analysis
No fundamental analysis for Life Stem Genetics yet.
Life Stem Genetics stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Life Stem Genetics
Life Stem Genetics Inc. does not have significant operations. Previously, it was engaged in stem cell and therapy research, as well as life science activities. The company was founded in 2012 and is based in East Stroudsburg, Pennsylvania.
Full company profileLife Stem Genetics financial statements
Life Stem Genetics annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2012 | 2013 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | - | - | - |
| Gross Profit | 0.00 | 0.00 | - | - | - |
| Operating Income | -38.8K | -38.8K | -40.8K | -10.5K | -9.70K |
| EBITDA | - | -38.7K | -40.8K | -10.5K | -9.70K |
| Net Income | 0.00 | -38.8K | -40.8K | -10.6K | -9.70K |
| EPS | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||
| Total Assets | 7.78K | 388.00 | - | - | - |
| Total Liabilities | 4.10K | 21.9K | - | - | - |
| Shareholders' Equity | 3.68K | -21.5K | - | - | - |
| Cash & Short-term Investments | 7.78K | 105.00 | - | - | - |
| Cash Flow | |||||
| Operating Cash Flow | -38.7K | -38.7K | - | - | - |
| Capital Expenditure | 350.00 | 350.00 | - | - | - |
| Free Cash Flow | - | -39.0K | - | - | - |
| Ratios | |||||
| ROE | 0.0% | - | - | - | - |
| ROA | 0.0% | -9,990.2% | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
Life Stem Genetics dividends
Life Stem Genetics has not paid dividends in the last 2 fiscal years.
Last stock split: 13:1 on Sep 20, 2013.
Who owns Life Stem Genetics
Ownership data of Life Stem Genetics is not available yet.
Life Stem Genetics company profile
- Company name
- Life Stem Genetics
- Ticker
- LIFS.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Biotechnology
- Fiscal year end
- July
- Address
- 3300 Parker Lane, East Stroudsburg, PA, United States, 18301
- Phone
- 310-279-5234
- Website
- -
About Life Stem Genetics
Life Stem Genetics Inc. does not have significant operations. Previously, it was engaged in stem cell and therapy research, as well as life science activities. The company was founded in 2012 and is based in East Stroudsburg, Pennsylvania.
Life Stem Genetics management
3- Ms. Gloria SimovCEO, President & Director · born 1986
- Ms. Heather SharpChief Financial Officer, Principal Accounting Officer, Vice President, Secretary and Director · born 1972
- Dr. Vino PadayacheeChairman & Business Development Director · born 1960